Tharimmune, Inc. Passive Investment Disclosure (>5%)
ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 3,252,033 shares of Tharimmune, Inc. common stock, representing 8.92% of the class as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 3,252,033 shares of Tharimmune, Inc. common stock, representing 8.92% of the class as of 12/31/2025.
ARK has sole power to vote and dispose of these 3,252,033 shares. Catherine Wood is reported with shared voting and dispositive power over the same shares. The securities are stated to be acquired and held in the ordinary course of business, not for changing or influencing control of Tharimmune.
Insights
ARK and Catherine Wood report a passive 8.92% stake in Tharimmune.
ARK Investment Management LLC and Catherine D. Wood disclose beneficial ownership of 3,252,033 Tharimmune common shares, or 8.92% of the class as of 12/31/2025. This crosses the 5% threshold that requires a Schedule 13G filing.
ARK holds sole voting and dispositive power over the shares, while Catherine Wood has shared voting and dispositive power, reflecting her control role at ARK. The certification states the position was acquired and is held in the ordinary course of business, and not to change or influence control of Tharimmune.
The filing characterizes this as a passive investment rather than an activist position. Future ownership reports and company filings may provide additional context on any changes in this stake or related governance developments.
AI-generated analysis. How Rhea-AI works. Not financial advice.